Pfizer Inc. (NYSE:PFE) will conduct an investor call on Tuesday to provide full-year 2025 financial guidance. Ahead of the ...

The stock's fall snapped a two-day winning streak.

With a market capitalization of more than $143 billion today, Pfizer (NYSE: PFE) stock won't make anyone into a millionaire ...

Pfizer's shares have significantly underperformed, but the current valuation and high dividend yield present a compelling ...

Pfizer just raised its dividend by 2.4% to $0.43, giving investors something to cheer about despite the stock’s lackluster ...

The efficacy data could help cushion Ibrance's losses of market share to Kisqali, a similar drug from Novartis.

SAN DIEGO — Pfizer’s abrupt withdrawal of its sickle cell drug Oxybryta over safety concerns was called “tone deaf” during a ...

Pfizer has a diversified portfolio, including successful vaccines and promising new drugs. Read more to see why I upgrade PFE ...

Today, Benzinga 's options scanner spotted 29 uncommon options trades for Pfizer. This isn't normal. The overall sentiment of ...

Goldman Sachs hosted a meeting with Pfizer Inc’s (NYSE:PFE) newly appointed Chief Scientific Officer Chris Boshoff (effective ...

Executives from Pfizer Inc and Amazon.com see opportunities for working with U.S. health secretary nominee Robert F. Kennedy ...

Pharmaceutical giant Pfizer (PFE) now sports a dividend yield of 6.5%. Is this stock a smart addition to the income section ...